218 related articles for article (PubMed ID: 23866045)
1. A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation.
Bergström SE; Bergdahl E; Sundqvist KG
Immunology; 2013 Dec; 140(4):441-55. PubMed ID: 23866045
[TBL] [Abstract][Full Text] [Related]
2. Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.
Bergström SE; Uzunel M; Talme T; Bergdahl E; Sundqvist KG
Immunology; 2015 Apr; 144(4):687-703. PubMed ID: 25393517
[TBL] [Abstract][Full Text] [Related]
3. Regulation of T-lymphocyte motility, adhesion and de-adhesion by a cell surface mechanism directed by low density lipoprotein receptor-related protein 1 and endogenous thrombospondin-1.
Talme T; Bergdahl E; Sundqvist KG
Immunology; 2014 Jun; 142(2):176-92. PubMed ID: 24877199
[TBL] [Abstract][Full Text] [Related]
4. T-cell regulation through a basic suppressive mechanism targeting low-density lipoprotein receptor-related protein 1.
Panezai J; Bergdahl E; Sundqvist KG
Immunology; 2017 Oct; 152(2):308-327. PubMed ID: 28580688
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1).
Talme T; Bergdahl E; Sundqvist KG
Eur J Immunol; 2016 May; 46(5):1279-90. PubMed ID: 26909742
[TBL] [Abstract][Full Text] [Related]
6. Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion.
Li SS; Liu Z; Uzunel M; Sundqvist KG
Blood; 2006 Nov; 108(9):3112-20. PubMed ID: 16835379
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.
Miller TW; Kaur S; Ivins-O'Keefe K; Roberts DD
Matrix Biol; 2013 Aug; 32(6):316-24. PubMed ID: 23499828
[TBL] [Abstract][Full Text] [Related]
8. Autocrine regulation of T cell motility by calreticulin-thrombospondin-1 interaction.
Li SS; Forslöw A; Sundqvist KG
J Immunol; 2005 Jan; 174(2):654-61. PubMed ID: 15634883
[TBL] [Abstract][Full Text] [Related]
9. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
10. A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals.
Liu Z; Christensson M; Forslöw A; De Meester I; Sundqvist KG
J Immunol; 2009 Sep; 183(6):3616-24. PubMed ID: 19687096
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.
Pallero MA; Elzie CA; Chen J; Mosher DF; Murphy-Ullrich JE
FASEB J; 2008 Nov; 22(11):3968-79. PubMed ID: 18653767
[TBL] [Abstract][Full Text] [Related]
12. CD47 Binding on Vascular Endothelial Cells Inhibits IL-17-Mediated Leukocyte Adhesion.
Soriano-Romaní L; Mir FA; Singh N; Chin I; Hafezi-Moghadam A; Masli S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628515
[TBL] [Abstract][Full Text] [Related]
13. CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade.
Sundqvist KG
Front Immunol; 2021; 12():670864. PubMed ID: 33968078
[No Abstract] [Full Text] [Related]
14. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
[TBL] [Abstract][Full Text] [Related]
16. LRP1 receptor-mediated immunosuppression of α-MMC on monocytes.
Deng N; Li M; Shen D; He Q; Sun W; Liu M; Liu Y; Zhou Y; Zheng J; Shen F
Int Immunopharmacol; 2019 May; 70():80-87. PubMed ID: 30785094
[TBL] [Abstract][Full Text] [Related]
17. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
Jinquan T; Quan S; Feili G; Larsen CG; Thestrup-Pedersen K
J Immunol; 1999 Apr; 162(7):4285-92. PubMed ID: 10201960
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.
Kamijo H; Miyagaki T; Takahashi-Shishido N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
Leukemia; 2020 Mar; 34(3):845-856. PubMed ID: 31712778
[TBL] [Abstract][Full Text] [Related]
19. T lymphocyte expression of thrombospondin-1 and adhesion to extracellular matrix components.
Li SS; Ivanoff A; Bergström SE; Sandström A; Christensson B; van Nerven J; Holgersson J; Hauzenberger D; Arencibia I; Sundqvist KG
Eur J Immunol; 2002 Apr; 32(4):1069-79. PubMed ID: 11920574
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis.
Rodríguez-Jiménez P; Chicharro P; Llamas-Velasco M; Cibrian D; Trigo-Torres L; Vara A; Jiménez-Fernández M; Sevilla-Montero J; Calzada MJ; Sánchez-Madrid F; de la Fuente H; Daudén E
Front Immunol; 2019; 10():1268. PubMed ID: 31214201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
